AGs Could Hinder Optimization of Healthcare Spending, Reduce Patients’ Options: Prof. Sakamaki

Prof. Sakamaki The entry of authorized generics (AGs) is expected to increase in the years ahead, but this could hinder the optimization of healthcare spending, said Hiroyuki Sakamaki, professor at Tokyo University of Sciences’ School of Management, in a recent...read more